Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancers in which alternative or compensatory pathways are often activated. Read more
G protein-coupled receptors (GPCRs) modulate the majority of physiological and pathological processes and constitute the largest family of cell surface receptors and drug targets. Read more
